Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Yang Liu, Jianying Liu, Bryan A. Johnson, et al.
Cell Reports (2022) Vol. 39, Iss. 7, pp. 110829-110829
Open Access | Times Cited: 351

Showing 1-25 of 351 citing articles:

SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 989
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
Chaitanya Kurhade, Jing Zou, Hongjie Xia, et al.
Nature Medicine (2022) Vol. 29, Iss. 2, pp. 344-347
Open Access | Times Cited: 381
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 342
Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 323
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 291
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
Christoph Jung, Dorota Kmieć, Lennart Koepke, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 203
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 872-880.e3
Open Access | Times Cited: 198
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
Bailey Lubinski, Maureen Hoch Vieira Fernandes, Laura E. Frazier, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103589-103589
Open Access | Times Cited: 194
Defining the risk of SARS-CoV-2 variants on immune protection
Marciela M. DeGrace, Elodie Ghedin, Matthew B. Frieman, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 640-652
Open Access | Times Cited: 154
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
Bryan A. Johnson, Yiyang Zhou, Kumari G. Lokugamage, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010627-e1010627
Open Access | Times Cited: 129
COVID-19 in pregnancy: implications for fetal brain development
Lydia L. Shook, Elinor L. Sullivan, Jamie O. Lo, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 4, pp. 319-330
Open Access | Times Cited: 119
Neutralization, effector function and immune imprinting of Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
Nature (2023) Vol. 621, Iss. 7979, pp. 592-601
Open Access | Times Cited: 117
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants
James W. Saville, Dhiraj Mannar, Xing Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 96
Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2
Kathryn E. Kistler, John Huddleston, Trevor Bedford
Cell Host & Microbe (2022) Vol. 30, Iss. 4, pp. 545-555.e4
Open Access | Times Cited: 92
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 91
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
Naoko Iwata‐Yoshikawa, Masatoshi Kakizaki, Nozomi Shiwa-Sudo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 83
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
Grigoris D. Amoutzias, Marios Nikolaidis, Eleni Tryfonopoulou, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 82
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 75
SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
Haolin Liu, Pengcheng Wei, John W. Kappler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 72
An early warning system for emerging SARS-CoV-2 variants
Lorenzo Subissi, Anne von Gottberg, Lipi Thukral, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1110-1115
Open Access | Times Cited: 72
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 72
White-tailed deer ( Odocoileus virginianus ) may serve as a wildlife reservoir for nearly extinct SARS-CoV-2 variants of concern
Leonardo C. Caserta, Mathias Martins, Salman L. Butt, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 6
Open Access | Times Cited: 69
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 51
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating
Nikhila S. Tanneti, Anant K. Patel, Li Tan, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 20
Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection
Jiakai Hou, Yanjun Wei, Jing Zou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top